📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

SARS-CoV-2 antigen testing: weighing the false positives against the costs of failing to control transmission. (2021)

First Author: Fearon E

Attributed to: Addressing the Social Determinants and Consequences of Tuberculosis (ASCOT): a pilot randomised controlled trial and process evaluation in Nepal funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/s2213-2600(21)00234-4

PubMed Identifier: 34139150

Publication URI: http://europepmc.org/abstract/MED/34139150

Type: Journal Article/Review

Volume: 9

Parent Publication: The Lancet. Respiratory medicine

Issue: 7

ISSN: 2213-2600